Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
For Wegovy (2.4 mg), nausea affects approximately 44% of patients, with diarrhea (30%), vomiting (24%), and constipation (24%) also commonly reported
Bank of America slashed their target to $30, calling the Novo split a trust killer and warning of significant revenue headwinds without Wegovy access
10.1016/j.phrs.2018.03.004 178
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs
US$ 22.25
US$ 28.44
US$ 24.59
US$ 28.70
